Status:
ACTIVE_NOT_RECRUITING
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Lead Sponsor:
Sheikh Zayed Federal Postgraduate Medical Institute
Collaborating Sponsors:
Punjab Institute of Cardology
Conditions:
ST Elevation (STEMI) Myocardial Infarction
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days
Eligibility Criteria
Inclusion
- Age 18-75 years Patients undergoing primary angiography
Exclusion
- Hemodynamically unstable patients. History or clinical evidence of any co-morbidities. Taking any medications regularly even statins.
Key Trial Info
Start Date :
December 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 2 2025
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06924684
Start Date
December 2 2024
End Date
July 2 2025
Last Update
April 11 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaikh Zayed Hsopital
Lahore, Pakistan, 54600
2
Punjab Institute of Cardiology
Lahore, Pakistan